Conexiant’s news site is now MDSpire News. Learn more
Advertisement
JIA-Associated Uveitis in Adults
Ophthalmologists caring for adults with this condition may encounter persistent inflammation, treatment dependence, and the cumulative ocular effects of childhood disease.
Persistent inflammation and treatment dependence due to childhood disease
Target Population
Adults with a history of juvenile idiopathic arthritis
Care Setting
Ophthalmology
Key Highlights
JIAU is the most common systemic disease-associated uveitis in childhood.
Many patients experience ongoing inflammation or complications into adulthood.
Common complications include cataract, glaucoma, and macular edema.
Remission of arthritis does not guarantee remission of uveitis.
Biologic therapy may change the natural history of JIAU.
Guideline-Based Recommendations
Diagnosis
Diagnosis typically occurs during childhood; ongoing monitoring is essential in adulthood.
Management
Topical corticosteroids are the initial treatment; systemic steroid-sparing immunomodulatory therapy is recommended when inflammation is not controlled.
Monitoring & Follow-up
Regular assessment for ocular complications and disease activity is necessary.
Risks
Prolonged corticosteroid use increases risks of cataract and glaucoma.
Patient & Prescribing Data
Adults with a history of JIAU, potentially with ongoing inflammation or complications.
Methotrexate and TNF inhibitors like adalimumab and infliximab are commonly used for refractory cases.
Clinical Best Practices
Assess ocular and articular disease activity separately, as they may not correlate.
Cautiously approach discontinuation of biologic therapy; consider risks of treatment failure.
